Literature DB >> 1448925

The restricted nature of HIV-1 tropism for cultured neural cells.

N Sharpless1, D Gilbert, B Vandercam, J M Zhou, E Verdin, G Ronnett, E Friedman, M Dubois-Dalcq.   

Abstract

Infection of the central nervous system by HIV-1, the agent of AIDS, is characterized by the presence of infected and giant microglial cells as well as astrocytosis, demyelination, and neuronal loss. To determine whether cells of neuroectoderm origin can be infected by HIV-1, we have inoculated primary cultures derived from adult human brain with a lymphotropic virus (LAV) or a neurotropic virus (Jr-FL) isolated from a patient with AIDS dementia. While Jr-FL invariably causes productive infection of cultured brain microglia, neither astrocytes nor oligodendrocytes became productively infected by these viral strains. Moreover, the cultured oligodendrocytes develop a normal network of processes and express differentiation antigens in the presence of an ongoing lytic infection of microglial cells. No HIV-1 proviral DNA was detected in primary astrocyte cultures devoid of microglial after inoculation of either HIV-1 strain. Similarly, the neuronal cell line HCN-1 in its differentiated state did not allow the virus to go through cycles of reverse transcription and replication. LAV, however, was able to replicate in undifferentiated HCN-1 cells. Thus, tropism of HIV-1 appears tightly restricted to only one type of differentiated cell in the CNS, the microglia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448925     DOI: 10.1016/0042-6822(92)90257-p

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

Review 1.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

2.  The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop.

Authors:  T M Ross; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

3.  Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent.

Authors:  Ashok Chauhan
Journal:  Microbes Infect       Date:  2015-06-02       Impact factor: 2.700

4.  Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

Authors:  M T Dittmar; G Simmons; Y Donaldson; P Simmonds; P R Clapham; T F Schulz; R A Weiss
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Apoptosis induced by HIV-1 infection of the central nervous system.

Authors:  B Shi; U De Girolami; J He; S Wang; A Lorenzo; J Busciglio; D Gabuzda
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells.

Authors:  L Villarete; T Somasundaram; R Ahmed
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43.

Authors:  A Bonavia; N Arbour; V W Yong; P J Talbot
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes.

Authors:  C Tornatore; K Meyers; W Atwood; K Conant; E Major
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 9.  Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations.

Authors:  Stephanie J Bissel; Clayton A Wiley
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

Review 10.  HIV-1 endocytosis in astrocytes: a kiss of death or survival of the fittest?

Authors:  Ashok Chauhan; Akshay Tikoo; Jankiben Patel; Arwa Mujahid Abdullah
Journal:  Neurosci Res       Date:  2014-09-08       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.